SummitMD

Angioplasty Summit 2004 > Syllabus

Welcome Course Director Hot Topic Invited Faculty Meeting at a Glance Program Abstracts Poster Abstracts - Guideline - Syllabus Factoid Expert Lectures Gallery 2004 Hotel Accommodations Exhibition Sights of Korea Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Drug-eluting stents: cost versus clinical benefit. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. Drug-eluting stents: costs versus clinical benefit. A paclitaxel-eluting stent for the prevention of coronary restenosis. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). New frontiers in cardiology: drug-eluting stents: Part II. New frontiers in cardiology: drug-eluting stents: Part I. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Vascular radiation in a drug-eluting stent world: it's not over till it's over. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.